Filamin A Is a Potential Driver of Breast Cancer Metastasis via Regulation of MMP-1.

Abstract

Recurrent metastasis is a major fatal cause of breast cancer. Regretfully, the driving force and the molecular beneath have not been fully illustrated yet. In this study, a cohort of breast cancer patients with locoregional metastasis was recruited. For them, we collected the matched samples of the primary tumor and metastatic tumor, and then we determined the mutation profiles with whole-exome sequencing (WES). On basis of the profiles, we identified a list of deleterious variants in eight susceptible genes. Of them, filamin A (FLNA) was considered a potential driver gene of metastasis, and its low expression could enhance 5 years' relapse survival rate by 15%. To prove the finding, we constructed a stable FLNA knockout tumor cell line, which manifested that the cell abilities of proliferation, migration, and invasion were significantly weakened in response to the gene knockout. Subsequently, xenograft mouse experiments further proved that FLNA knockout could inhibit local or distal metastasis. Putting all the results together, we consolidated that FLNA could be a potential driver gene to metastasis of breast cancer, in particular triple-negative breast cancer. Additional experiments also suggested that FLNA might intervene in metastasis via the regulation of MMP-1 expression. In summary, this study demonstrates that FLNA may play as a positive regulator in cancer proliferation and recurrence. It provides new insight into breast cancer metastasis and suggests a potential new therapeutic target for breast cancer therapy.

• Authors: Jie Zhou, Lvying Wu, Pengyan Xu, Yue Li, Zhiliang Ji, Xinmei Kang
• Journal: Frontiers in oncology (Front Oncol) Vol. 12 Pg. 836126 ( 2022) ISSN: 2234-943X [Print] Switzerland
• PMID: 35359350 (Publication Type: Journal Article)
• Copyright: Copyright © 2022 Zhou, Wu, Xu, Li, Ji and Kang.